| Prev Close | 214.02 |
| Day Low/High | 212.15 / 214.24 |
| 52 Wk Low/High | 160.63 / 244.75 |
Constellation Brands, Inc. Class A (STZ)
212.62
NYSE
| Exchange | NYSE |
| Shares Outstanding | 192.03B |
| Market Cap | 41.10B |
| P/E Ratio | 21.86 |
| Div & Yield | N.A. (N.A) |
Buyers Belly Up to Constellation Brands After Wednesday's Big Stumble
A number of analysts maintain the beer and wine giant's valuation is even more attractive for long-term investors thanks to a sharp decline in its shares.
Jim Cramer: Constellation Brands Continues to Look Intriguing
Even with its 12% stock decline on Wednesday, Constellation Brands is more intriguing than it was yesterday.
Constellation Brands Still Has a Lot to Prove
The company's third quarter was a mixed bag.
Paradise (Partially) Lost!
It's amazing how this business works. I launched my Canopy Growth Corp. analysis about three weeks ago in conjunction with my analysis of Constellation Brands (down by -$21/share today) -- as STZ had recently made the big investment in CGC. My concl...
Trade Resolution Would Keep This Correction From Becoming a Crash: Market Recon
Plus, a resolution of the government shut-down needs to happen soon.
Real Money Goes Behind the Scenes of the Budding Cannabis Industry
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
Constellation Brands Could Satisfy Your Thirst for a Trade From the Long Side
Aggressive traders could probe the long side of STZ at current levels and on a shallow dip.
Who Hasn't Crashed the Cannabis Party Yet?
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Tilray Is Now a Top-Tier Cannabis Play
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
Tilray Stock Burns Higher With Anheuser-Busch Beverage Deal
Pot stock partnerships are a gateway to gains for cannabis investors.
Here's Why I See Potential With Aphria
The stock is finally down to realistic levels.
Big Tobacco Hasn't Killed Cannabis, This Dance Has Only Just Begun
After Altria's investment in Cronos Group, which cannabis company will be the next target?
Constellation Brands Is Giving Us Subtle Clues That It Wants to Rally
Turns to the upside and downside can be subtle but it looks like Constellation Brands is giving us some subtle bullish clues.
Jim Cramer: What If Trump Tweets Xi Forced Him to Ignite the 25% Tariff Fuse?
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.
Here's Why Tilray Stock Is the Wild Child
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Tilray Stock Higher Ahead of First Post-Legalization Earnings Release
Tilray will have a lot to tackle this evening.
Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
What Barclays Gets Wrong About Cannabis and Tobacco
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
Constellation Brands Shows a Curious Mix of Charts and Indicators
Constellation Brands is the kind of company that typically does well in a weak market environment.
CGC Is the One Must-Own Cannabis Stock
Canopy Growth already has a $4 billion war chest thanks to Constellation Brands.
Check Out These Stocks as Canada Is About to Be Smokin' Hot
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
Jim Cramer: Wednesday Is a Watershed Day for Cannabis Stocks
But don't buy into this overheated market right as Canada legalizes, wait until prices come down -- which they will.
Canopy Growth Is Poised to Explode to the Upside
Let's look at the charts and technical indicators.
Jim Cramer: I'm Not Saying the Fed's Gone Crazy, I'm Saying It's Gone Lazy
The Fed's crystal ball is very clouded.
Play a Potential Altria Pivot Into Pot
The time to scoop up Altria is now, not when some type of official announcement is made.
Canopy Growth and 4 Other Cannabis Stocks That Look Good Here
These stocks offer some diversification or unique features in the legal-weed space.
Chart of the Day: Constellation's Canopy Growth Engine
Canopy Growth could be Constellation's next big growth engine.
